Cognitive behavioral therapy adds no value to drug treatment for opioid dependence

January 4, 2013 by Helen Dodson
Cognitive behavioral therapy adds no value to drug treatment for opioid dependence
Credit: Shutterstock

(Medical Xpress)—In a surprise finding, Yale researchers report that adding cognitive behavioral therapy to the most commonly used drug treatment for opioid dependence does not further reduce illicit drug use by patients. The study, which could change how such dependence is viewed and treated in the U.S. healthcare system, appears online in the American Journal of Medicine.

The medication, , has been in use for a decade, and is now prescribed to treat opioid dependence more than any other medication of its kind. Prescription by primary care and office-based physicians accounts for much of this increase. Cognitive behavioral therapy (CBT) is an intervention that has demonstrated effectiveness for many psychiatric conditions and substance use disorders, even beyond the period of treatment, but the impact of combining it with buprenorphine has not been clear until now.

To assess the impact, researchers conducted a involving 141 opioid-dependent patients in a primary care clinic. The patients were divided into two groups: those who received buprenorphine treatment alone under the care of a physician, and those who received the buprenorphine and professionally administered cognitive behavioral therapy.

The two treatments showed similar effectiveness – a significant reduction in self-reported frequency of opioid use. But the group receiving showed no more reduction in use than those receiving buprenorphine and physician care.

This finding contrasts with earlier studies that demonstrated improved outcomes with counseling services in patients receiving . But the Yale team notes that the key to success in the non-CBT group was that they were still under a primary physician's care while receiving buprenorphine – even if there was only a limited amount of counseling provided.

"This study demonstrates that some patients can do very well with buprenorphine and minimal physician support. This treatment represents an important tool to help reduce the adverse impact of addiction, HIV, and overdose due to heroin and prescription opioids," said lead author Dr. David A. Fiellin, professor of medicine, investigative medicine, and public health at Yale School of Medicine.

Explore further: Suboxone is most effective in treating painkiller addiction

Related Stories

Suboxone is most effective in treating painkiller addiction

November 7, 2011

Individuals addicted to prescription painkillers are more likely to succeed in treatment with the aid of the medication buprenorphine-naloxone (Suboxone), report McLean Hospital and Harvard Medical School researchers in today's ...

Recommended for you

How much video gaming is too much for kids?

September 27, 2016

(HealthDay)—Playing video games might improve a child's motor skills, reaction time and even academic performance, but new research shows that too much gaming can be linked to social and behavioral problems.

How we handle objects depends on who owns them

September 27, 2016

From scissors and staplers to car keys and cell phones, we pass objects to other people every day. We often try to pass the objects so that the handle or other useful feature is facing the appropriate direction for the person ...

Dogs ignore bad advice that humans follow

September 27, 2016

Dogs are less likely to follow bad advice than children, according to a new study conducted at the Canine Cognition Center at Yale. In contrast to children, dogs only copy a human's actions if they are absolutely necessary ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.